Trofosfamide

Trofosfamide (INN) is a nitrogen mustard alkylating agent. It is sometimes abbreviated "TRO".[1] It has been used in trials to study its effects on Ependymomas, Medulloblastomas, Sarcoma, Soft Tissue, Supratentorial PNETs, and Recurrent Brain Tumors.[2]

Trofosfamide
Clinical data
Trade namesIxoten
AHFS/Drugs.comInternational Drug Names
Routes of
administration
By mouth (film-coated tablets)
ATC code
Legal status
Legal status
  • DE: § 48 AMG/§ 1 MPAV (Prescription only)
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
ECHA InfoCard100.040.686
Chemical and physical data
FormulaC9H18Cl3N2O2P
Molar mass323.58 g·mol−1
3D model (JSmol)
 NY (what is this?)  (verify)

References

  1. Jahnke K, Thiel E, Bechrakis NE, et al. (December 2008). "Ifosfamide or trofosfamide in patients with intraocular lymphoma". J. Neurooncol. 93 (2): 213–7. doi:10.1007/s11060-008-9761-8. PMID 19099202.
  2. "Trofosfamide". www.drugbank.ca. Retrieved 2019-12-19.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.